Free Trial

Exchange Traded Concepts LLC Has $1.87 Million Stock Position in Addus HomeCare Corporation (NASDAQ:ADUS)

Addus HomeCare logo with Medical background

Exchange Traded Concepts LLC lifted its position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 219.4% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,921 shares of the company's stock after buying an additional 12,998 shares during the period. Exchange Traded Concepts LLC owned approximately 0.10% of Addus HomeCare worth $1,871,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Capital Research Global Investors bought a new stake in Addus HomeCare in the fourth quarter worth about $51,149,000. American Century Companies Inc. increased its holdings in shares of Addus HomeCare by 695.8% in the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company's stock valued at $35,643,000 after buying an additional 248,613 shares in the last quarter. GAMMA Investing LLC increased its holdings in shares of Addus HomeCare by 10,307.8% in the first quarter. GAMMA Investing LLC now owns 130,930 shares of the company's stock valued at $12,948,000 after buying an additional 129,672 shares in the last quarter. Bank of America Corp DE increased its holdings in shares of Addus HomeCare by 273.6% in the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after buying an additional 128,211 shares in the last quarter. Finally, TimesSquare Capital Management LLC increased its holdings in shares of Addus HomeCare by 28.5% in the fourth quarter. TimesSquare Capital Management LLC now owns 355,750 shares of the company's stock valued at $44,593,000 after buying an additional 78,835 shares in the last quarter. Institutional investors own 95.35% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on ADUS. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 target price on shares of Addus HomeCare in a research report on Friday. Stephens restated an "overweight" rating and set a $142.00 price target on shares of Addus HomeCare in a report on Wednesday, March 12th. Wall Street Zen lowered shares of Addus HomeCare from a "buy" rating to a "hold" rating in a report on Saturday. Finally, Macquarie reissued an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a research note on Tuesday, June 10th. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus price target of $142.57.

Read Our Latest Analysis on Addus HomeCare

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president now directly owns 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 4.60% of the stock is currently owned by insiders.

Addus HomeCare Stock Down 1.2%

ADUS stock traded down $1.37 during trading hours on Friday, hitting $113.79. The company's stock had a trading volume of 195,824 shares, compared to its average volume of 170,637. The stock has a 50 day moving average price of $108.91 and a two-hundred day moving average price of $111.90. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The company has a market capitalization of $2.09 billion, a PE ratio of 25.69, a price-to-earnings-growth ratio of 1.61 and a beta of 0.81. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.42 EPS for the quarter, topping the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to the consensus estimate of $341.66 million. Addus HomeCare had a net margin of 6.52% and a return on equity of 9.23%. The business's quarterly revenue was up 20.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.21 earnings per share. On average, equities research analysts expect that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Should You Invest $1,000 in Addus HomeCare Right Now?

Before you consider Addus HomeCare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.

While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Time to Cash Out? 5 Stocks to Drop Before Earnings
Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines